CEACAM6 and inflammatory bowel disease: Further, IBD patients who are heterozygous (CT) or homozygous (CC) for the PTPN2 susceptibility variant rs1893217, displayed increased colonic CEACAM6 expression compared to PTPN2 wildtype (TT) controls.